Dergi makalesi Açık Erişim

Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring

Nakhle, Jean; Khattar, Khattar; Ozkan, Tuelin; Boughlita, Adel; Moussa, Daouda Abba; Darlix, Amelie; Lorcy, Frederique; Rigau, Valerie; Bauchet, Luc; Gerbal-Chaloin, Sabine; Daujat-Chavanieu, Martine; Bellvert, Floriant; Turchi, Laurent; Virolle, Thierry; Hugnot, Jean-Philippe; Buisine, Nicolas; Galloni, Mireille; Dardalhon, Valerie; Rodriguez, Anne-Marie; Vignais, Marie-Luce


MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Khattar, Khattar</subfield>
    <subfield code="u">Univ Montpellier, Inst Funct Genom, CNRS, INSERM, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozkan, Tuelin</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Boughlita, Adel</subfield>
    <subfield code="u">Univ Montpellier, Inst Regenerat Med &amp; Biotherapy, INSERM, CHU Montpellier, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Moussa, Daouda Abba</subfield>
    <subfield code="u">Univ Montpellier, Inst Regenerat Med &amp; Biotherapy, INSERM, CHU Montpellier, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Darlix, Amelie</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Lorcy, Frederique</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Rigau, Valerie</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Bauchet, Luc</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Gerbal-Chaloin, Sabine</subfield>
    <subfield code="u">Univ Montpellier, Inst Regenerat Med &amp; Biotherapy, INSERM, CHU Montpellier, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Daujat-Chavanieu, Martine</subfield>
    <subfield code="u">Univ Montpellier, Inst Regenerat Med &amp; Biotherapy, INSERM, CHU Montpellier, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Bellvert, Floriant</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Turchi, Laurent</subfield>
    <subfield code="u">Univ Cote Azur, Inst Biol Valrose, CNRS, Team INSERM,Canc Stem Cell Plast &amp; Funct Intratumo, Nice, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Virolle, Thierry</subfield>
    <subfield code="u">Univ Cote Azur, Inst Biol Valrose, CNRS, Team INSERM,Canc Stem Cell Plast &amp; Funct Intratumo, Nice, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Hugnot, Jean-Philippe</subfield>
    <subfield code="u">Univ Montpellier, Inst Funct Genom, CNRS, INSERM, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Buisine, Nicolas</subfield>
    <subfield code="u">Museum Natl Hist Nat, Physiol Mol &amp; Adaptat, CNRS, UMR7221, Paris, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Galloni, Mireille</subfield>
    <subfield code="u">Univ Montpellier, Inst Regenerat Med &amp; Biotherapy, INSERM, CHU Montpellier, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Dardalhon, Valerie</subfield>
    <subfield code="u">Univ Montpellier, Inst Mol Genet Montpellier, CNRS, Montpellier, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Rodriguez, Anne-Marie</subfield>
    <subfield code="u">Sorbonne Univ, Inst Biol Paris Seine IBPS, CNRS, INSERM,ERL,U1164,UMR 8256,Biol Adaptat &amp; Ageing, Paris, France</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Vignais, Marie-Luce</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">CANCER RESEARCH COMMUNICATIONS</subfield>
    <subfield code="v">3</subfield>
    <subfield code="n">6</subfield>
    <subfield code="c">16</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1158/2767-9764.CRC-23-0144</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Nakhle, Jean</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:aperta.ulakbim.gov.tr:271236</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2023-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/271236/files/bib-21494266-e830-4100-842f-f3138d9c5076.txt</subfield>
    <subfield code="z">md5:5e9533e63c38a39e544afb7b0f4d7b3d</subfield>
    <subfield code="s">458</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20240607163131.0</controlfield>
  <controlfield tag="001">271236</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Glioblastomas (GBM) are heterogeneous tumors with high metabolic plasticity. Their poor prognosis is linked to the presence of glioblastoma stem cells (GSC), which support resistance to therapy, notably to temozolomide (TMZ). Mesenchymal stem cells (MSC) recruitment to GBM contributes to GSC chemoresistance, by mechanisms still poorly understood. Here, we provide evidence that MSCs transfer mitochondria to GSCs through tunneling nanotubes, which enhances GSCs resistance to TMZ. More precisely, our metabolomics analyses reveal that MSC mitochondria induce GSCs metabolic reprograming, with a nutrient shift from glucose to glutamine, a rewiring of the tricarboxylic acid cycle from glutaminolysis to reductive carboxylation and increase in orotate turnover as well as in pyrimidine and purine synthesis. Metabolomics analysis of GBM patient tissues at relapse after TMZ treatment documents increased concentrations of AMP, CMP, GMP, and UMP nucleotides and thus corroborate our in vitro analyses. Finally, we provide a mechanism whereby mitochondrial transfer from MSCs to GSCs contributes to GBM resistance to TMZ therapy, by demonstrating that inhibition of orotate production by Brequinar (BRQ) restores TMZ sensitivity in GSCs with acquired mitochondria. Altogether, these results identify a mechanism for GBM resistance to TMZ and reveal a metabolic dependency of chemoresistant GBM following the acquisition of exogenous mitochondria, which opens therapeutic perspectives based on synthetic lethality between TMZ and BRQ.Significance: Mitochondria acquired from MSCs enhance the chemoresistance of GBMs. The discovery that they also generate metabolic vulnerability in GSCs paves the way for novel therapeutic approaches.&lt;/p&gt;</subfield>
  </datafield>
</record>
0
0
görüntülenme
indirilme
Görüntülenme 0
İndirme 0
Veri hacmi 0 Bytes
Tekil görüntülenme 0
Tekil indirme 0

Alıntı yap